FDA clears Optellum's lung cancer diagnosis software

By AuntMinnie.com staff writers

March 23, 2021 -- The U.S. Food and Drug Administration (FDA) has cleared artificial intelligence (AI) software developer Optellum's clinical decision-support software for lung cancer diagnosis.

Virtual Nodule Clinic helps radiologists to identify and track patients with small lung lesions that could be early-stage cancer, Optellum said. It features a lung cancer prediction scoring tool based on AI and radiomics that draws features from CT scans to assess lung lesions.

Optellum, Mirada present lung cancer study at RSNA 2017
Artificial intelligence (AI) software developer Optellum and imaging software developer Mirada Medical have partnered on deep learning and presented a...
Optellum unveils lung cancer analysis software
Artificial intelligence software developer Optellum said it will showcase a prototype of its deep learning-based lung nodule risk stratification software...

Copyright © 2021 AuntMinnie.com

Last Updated mf 3/23/2021 10:32:34 AM